POICX
Price
$11.64
Change
+$0.05 (+0.43%)
Updated
Jul 3 closing price
Net Assets
654.98M
RLBCX
Price
$36.64
Change
+$0.18 (+0.49%)
Updated
Jul 3 closing price
Net Assets
252.39B
Interact to see
Advertisement

POICX vs RLBCX

Header iconPOICX vs RLBCX Comparison
Open Charts POICX vs RLBCXBanner chart's image
Virtus Tactical Allocation C
Price$11.64
Change+$0.05 (+0.43%)
VolumeN/A
Net Assets654.98M
American Funds American Balanced R3
Price$36.64
Change+$0.18 (+0.49%)
VolumeN/A
Net Assets252.39B
POICX vs RLBCX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
POICX vs. RLBCX commentary
Jul 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is POICX is a Buy and RLBCX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RLBCX has more cash in the bank: 252B vs. POICX (655M). RLBCX pays higher dividends than POICX: RLBCX (1.57) vs POICX (0.83). POICX was incepted earlier than RLBCX: POICX (26 years) vs RLBCX (23 years). POICX (1.87) is less costly to investors than RLBCX (0.89). RLBCX is a more actively managed with annual turnover of: 44.00 vs. POICX (37.00). RLBCX has a lower initial minimum investment than POICX: RLBCX (250) vs POICX (2500). RLBCX annual gain was more profitable for investors over the last year : 7.52 vs. POICX (1.07). RLBCX return over 5 years is better than : 39.59 vs. POICX (3.99).
POICXRLBCXPOICX / RLBCX
Total Expense Ratio1.750.89197%
Annual Report Gross Expense Ratio1.870.89210%
Fund Existence26 years23 years-
Gain YTD7.7237.91798%
Front LoadN/AN/A-
Min. Initial Investment25002501,000%
Min. Initial Investment IRAN/AN/A-
Net Assets655M252B0%
Annual Yield % from dividends0.831.5753%
Returns for 1 year1.077.5214%
Returns for 3 years24.3334.0172%
Returns for 5 years3.9939.5910%
Returns for 10 years29.2762.1447%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GDEV15.750.65
+4.30%
GDEV Inc
FN294.665.83
+2.02%
Fabrinet
CGON26.900.22
+0.82%
CG Oncology
PTIX3.46-0.02
-0.57%
Protagenic Therapeutics Inc
NINE0.84-0.02
-2.73%
Nine Energy Service